Case Reports in Pathology
Volume 2016 (2016), Article ID 2494175, 6 pages
http://dx.doi.org/10.1155/2016/2494175

Case Report

Intraventricular Neurilemmoma (Schwannoma): Shall GFAP Immunostaining Be Regarded as a Histogenetical Tag or as a Mere Histomimetical Trait?

Miguel Fdo. Salazar,¹ Martha Lilia Tena Suck,² Daniel Rembao Bojórquez,² and Citlaltepetl Salinas Lara²

¹Pathology Unit, Neuropathology Service, Mexico General Hospital, Cuauhtémoc, 06726 Mexico City, DF, Mexico
²Department of Neuropathology, National Institute of Neurology & Neurosurgery “Manuel Velasco Suárez”, Tlalpan, 14269 Mexico City, DF, Mexico

Received 10 May 2016; Accepted 5 June 2016

Academic Editor: José Pimentel

Copyright © 2016 Miguel Fdo. Salazar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Neurilemmomas are benign neoplasms presumedly derived from Schwann cells which rarely originate within the central nervous system. Moreover, their intraventricular location has been seldom noticed with less than 30 cases reported worldwide. Here, we add another case study to the record as well as the fifth one in Latin American population. A 16-year-old boy without significant past clinical data debuted with headache and progressive left eye blindness during six months. Neuroimaging scans showed a bulky, multiloculated, intraventricular tumour emerging from the posterior horn of the left lateral ventricle. Microscopically, the lesion put on view the classical schwannian histology: spindle cells arranged in both compact and loosely textured areas. Verocay bodies were not present but vessel hyalinisation, pericellular reticulin, and senescent atypia were observed. The immunoperoxidase reactions were also consistent with neurilemmal differentiation; however, glial fibrillary acidic protein expression was widespread and unexpectedly seen. Traditionally conceived as “nerve sheath tumours” the dual immunophenotype herein demonstrated points to a different histogenetical pathway other than sheer Schwann cell derivation. As previously advised by some authors, neoplastic transformation from a multipotent stem cell may explain the occasional finding of these tumours in unconventional intracranial compartments.

1. Introduction

Canonically assumed to sprout from tissue encasing nerve extensions, the so-called nerve sheath, neurilemmomas prove to show a Schwann cell phenotype, hence their more popular designation which springs their name: schwannomas. The vast majority of neurilemmomas grow outside the central nervous system or are associated with spinal nerve roots [1]. Intracranial examples, on the other hand, are usually attached to cranial nerves, most commonly VIII, V, VII, and XII [1, 2], but have been also seldom noticed in intraaxial and intraventricular locations [1]. The latter represents the most uncommon topography, with nearly thirty case reports written worldwide [3–29]. Here, we present the 29th case as well as the fifth one registered in Latin America (Table 1).

Table 1: Intraventricular neurilemmomas case list.

Case number
Year
Author [reference] (country)
Age/gender
Location

1
1965
David et al. [8] (France)
15♂
Lateral ventricle

2
1975
Ghatak et al. [9] (USA)
63♀
Lateral ventricle

3
1975
Van Rensburg et al. [10] (South Africa)
21♂
Lateral ventricle (cornu temporale)

4
1988
Pimentel et al. [11] (Portugal)
8♂
Lateral ventricle (right)

5
1990
Ost and Meyer [12] (USA)
44♂
Lateral ventricle (left; cornu occipitale)

6
1990
Redekop et al. [13] (Canada)
7♂
4th ventricle

7
1993
Weiner et al. [14] (USA)
61♂
4th ventricle

8
1993
Weiner et al. [14] (USA)
78♀
4th ventricle

9
2001
Barbosa et al. [15] (Portugal)
13♀
Lateral ventricle (atrium)

10
2002
Estrada et al. [16] (Mexico)
36♀
4th ventricle

11
2003
Erdogan et al. [17] (Turkey)
21♂
Lateral ventricle

12
2004
Dow et al. [18] (UK)
16♂
Lateral ventricle (right; atrium)

13
2006
Messing-Jünger et al. [19] (Germany)
21♀
3rd ventricle

14
2007
Lévêque et al. [20] (Belgium)
16♂
Lateral ventricle (right)

15
2008
Benedict et al. [21] (USA)
15♂
Lateral ventricle (right; cornu occipitale)

16
2009
Oertel et al. [22] (Germany)
71♀
4th ventricle (   variant)

17
2009
De Vasconcellos et al. [7] (Brazil)
21♀
Lateral ventricle (left; atrium)

18
2010
Martin et al. [23] (Czech Republic)
70♀
3rd ventricle

19
2011
Hodges et al. [6] (USA)
69♂
4th ventricle

20
2012
Kachhara et al. [24] (India)
30♂
4th ventricle

21
2013
Chen et al. [25] (China)
53♀
4th ventricle

22
2013
Luo et al. [4] (China)
24♂
Lateral ventricle (right)

23
2013
Jaimovich et al. [26] (Argentina)
16♂
Lateral ventricle (right; cornu occipitale)

24
2013
Alberione et al. [27] (Argentina)
41♀
Lateral ventricle (right; cornu occipitale)

25
2015
Li et al. [28] (China)
23♂
3rd ventricle

26
2015
Glikstein et al. [29] (Canada)
34♂
Lateral ventricle (left)

27
2015
Currán-Meléndez et al. [3] (USA)
20♂
Lateral ventricle (right; atrium)

28
2016
Abdolhosseinpour et al. [5] (Iran)
9♂
Lateral ventricle (left; atrium)

29
2016
Present Case (Mexico)
16♂
Lateral ventricle (left; cornu occipitale)

Statistical summary 

Adults: 19 (65.5%) paediatric: 10 (34.5%) mean age: 32 y

Male: 19 (65.5%) female 10 (34.5%)

Age range: 7 y to 78 y

Lateral ventricles: 18 (62%) 3rd ventricle: 3 (10.3%) 4th ventricle: 8 (27.6%)

♂: male, ♀: female, y: years.

Special histopathological variant.

2. Case Report

A 16-year-old boy without any pathological, genetic, or familial history of significance suffered from headaches and intermittent blurry vision during six months; he got alarmed when his left eye vision was completely lost and presented to an urgent care facility. Magnetic resonance imaging scans showed an intraventricular, irregularly nodular, space-occupying lesion emerging from the posterior horn of the left lateral ventricle (Figure 1(a)). A gray-yellow tumour attached to the glomus choroideum was excised in integrum by the surgeon; histopathological examination disclosed a biphasic neoplasm laid out in densely packed fascicles of spindle cells with elongated nuclei (Antoni A pattern) as well as loosely clustered, hypocellular areas in a myxoid background (Antoni B pattern) (Figure 1(b)). Although Verocay bodies were not conspicuous, some blood vessels had hyalinised walls (Figure 1(c)) while a reticulin lattice enveloped every single cell (Figure 1(d)). Senescent changes were also present, with isolated cells in the Antoni B areas displaying a round, voluminous, eosinophilic cytoplasm with a displaced atypical nucleus; some of them even resembled a gemistocytic morphophenotype (Figures 1(e)–1(g)). The immunohistochemistry panel confirmed the diagnosis of neurilemmoma: PS100⁽⁺⁾, collagen IV⁽⁺⁾, and vimentin⁽⁺⁾ (Figures 2(a) and 2(b)), but also unveiled a diffuse labelling for glial fibrillary acidic protein (GFAP) in both Antony patterns (Figures 2(c) and 2(d)). Thus, according to the aforementioned traits, the case was regarded as an intraventricular neurilemmoma.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

Figure 1: Magnetic resonance imaging scans/histopathological findings. (a) Postcontrast T₁ (right) and T₂ weighted (center) sequences demonstrate a cystic, avidly enhancing mass, while the fluid-attenuated inversion recovery (FLAIR) sequence (left) shows enlargement of the cornu occipitale sinister with surrounding white matter oedema, consistent with ventricular entrapment; this might as well explain the blurred vision due to affection of the geniculocalcarine tract. (b) Transition zone, in a spindle cell neoplastic population, from an Antony A pattern (left) to an Antony B area (right). H&E. (c) High magnification photomicrograph showing intratumoural hyalinised vessels. H&E. (d) Reticular fibers stain. A pericellular reticulin frame, trademark of neurilemmal phenotype, is noticeable. (e) Antony B field with a small population of neoplastic, plump, gemistocyte-like cells. H&E. ((f), (g)) High magnification photomicrographs of the cells shown in (e): voluminous cells with eccentric nuclei and senescent atypia are evident.

(a)

(b)

(c)

(d)

Figure 2: Immunohistochemistry panel. (a) PS100. (b) Collagen IV. ((c), (d)) Glial fibrillary acidic protein (GFAP) in an Antony A area (c) and in Antony B gemistocyte-like cells (d).

3. Discussion

It has been estimated that neurilemmomas account for approximately 10% of intracranial tumours, the majority of them (~85%) arising at the cerebellopontine angle [1, 3, 4]. Conversely, the intraventricular location is very unusual; for instance, in the series published by Luo et al. [4] about 18 non-cranial nerve related neurilemmomas—the largest up to date—only one (0.055%) was intraventricular. Our surveillance revealed just 28 cases documented from 1965 to the present (Table 1). Moreover, none of them has been associated with either neurofibromatosis or any other phakomatoses. It is worth mentioning the existence of three more cases labeled as malignant schwannomas [30–32]; however, we decided to cast them aside as they correspond in fact to neurogenic sarcomas, that is, malignant peripheral nerve sheath tumours (MPNST), and, thus, are not true neurilemmomas.

Etiopathogenesis of such a neoplasm within the cerebral ventricles is perplexing and, hence, several hypotheses have been introduced [3–7]: (1) growth from autonomic nerve cells inherent to choroid plexus or from nervi vasorum, a premise based on the identification of the former by Benedikt in 1874 and confirmed by Stöhr in 1922 [33, 34] (also, the apparent attachment to choroid plexus supports this conjecture), (2) development from displaced neural crest cells which, in turn, may give rise to ectopic Schwann cells, and (3) neoplastic transformation of multipotent stem cells. Although no sole speculation may be sufficient to explain every single case—as different, nonexcluding mechanisms shall be involved—recent advances in the recognition of the so-called “neural stem cells” make the third assumption particularly attractive. Indeed, Doetsch et al. [35] confirmed the existence of such a lineage placed in the subventricular zone; furthermore, they seem to bear the cardinal phenotypical traits of astrocytes. Interestingly, it is well known that, in contrast to their peripheral counterpart, non-cranial nerve related neurilemmomas are more prone to diffusely express GFAP [3]. Unfortunately, just a couple of reports emphasise this difference and demonstrate it in their photographs [5–7]. In this regard, we share the opinion of Luo et al. [4] stating that at least this subset of neurilemmomas arises from neoplastic transformation of subventricular pluripotent stem cells, hence preserving parental GFAP⁽⁺⁾ immunophenotype which may in fact represent some kind of histogenetical imprinting.

The clinical presentation of intraventricular neurilemmomas generally involves headache, nausea, and vomiting; however, brachial-crural hemiparesis, seizures, vertigo, and visual symptoms such as homonymous hemianopsia and transient scintillating scotomas have also been reported [3–7]. On the other hand, common neuroradiological features include a heterogeneously enhancing, predominantly solid mass with intralesional cysts and overstressed peritumoural oedema [3–7].

Differential diagnoses in our setting include cystic ventricular-extending astrocytoma, cystic meningioma, ependymoma, choroid plexus papilloma or carcinoma, haemangioblastoma, and metastatic lesions [3, 5–7]. Some morphological traits such as absence of papillary stalks lined by a single layer of uniform cuboidal/cylindrical epithelial cells, nonattendance of plump lipid-laden multivacuolated stromal cells, or lack of foreign carcinomatous/sarcomatous invading cells easily discard the latter by simple light microscopy examination. Conversely, ependymoma, meningioma, and astrocytoma may demand further analysis by means of immunohistochemical evaluation. In this regard, employment of reagents such as PS100, GFAP, epithelial membrane antigen (EMA), cytokeratin-18 (CK-18), progesterone receptors (PR), and vimentin should be useful to guide diagnosis: for instance, diffuse EMA, CK18, PR, and vimentin immunolabeling is akin to meningiomas while PS100, GFAP, and ring/dot-like EMA positivity is seen in ependymomas. Of particular interest and difficulty to exclude in our case are pilocytic astrocytoma and tanycytic ependymoma, as both of them share a long spindle cell morphology as well as PS100, GFAP, and vimentin immunostaining; none of them, however, bear the distinctive reticulin lattice of neurilemmomas which corresponds to the continuous basal lamina coating every single neoplastic Schwann cell. Moreover, in spite of PS100 common employment as a key immunohistochemical marker for schwannian neoplasms, it is not essentially needed, as sole H&E morphology is diagnostic (Antoni growth patterns, Verocay bodies, lipid-laden cells, and thick-walled hyalinised vasculature). Curiously, it is well known that intracranial neurilemmomas usually lack formation of Verocay figures [1].

Finally, does GFAP positivity in neurilemmomas solve the puzzling issue of etiopathogenesis? Not necessarily, as this hypothesis is based on casual observations rather than explicit experimental data. Nevertheless, we think it is firmly revealing. On the other hand, there might be the possibility for the neoplastic cell to adopt new lineage clusters, a phenomenon we have coined as histomimesis, and, thus, it would not reliably reflect its native roots. Whether it is one way or the other is a field of inquiry.

In spite of their exceptional rarity, neurilemmal neoplasms are a diagnosis to consider during the evaluation of intraventricular tumours, making the recognition of this benign and potentially curable lesion of obvious importance. Hence, we add a new case of intraventricular neurilemmoma, the twenty-ninth one to the global registry as well as the fifth known to Latin American population.

Ethical Approval

All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Consent

Informed consent was obtained from the patient’s legal guardian and anonymity of the patient is preserved.

Competing Interests

The authors declare no conflict of interests.

Acknowledgments

It is a genuine pleasure to the authors of this short and unpretentious text to express their deep sense of gratitude to Dr. Leila Chimelli, M.D., Ph.D., neuropathologist at the Serviço de Anatomia Patológica, Hospital Universitário, Universidade Federal do Rio de Janeiro, Brazil, for her expert opinion and critical evaluation of this paper in its unpublished version. But, most importantly, they would like to share this achievement with her as well as to show their warm-hearted appreciation to a humble, kind, and clever woman who has also shared her invaluable friendship with them.

References

B. W. Scheithauer, D. N. Louis, S. Hunter, J. M. Woodruff, and C. R. Antonescu, “Schwannoma,” in WHO Classification of Tumours of the Central Nervous System, D. N. Louis, H. Ohgaki, O. D. Wiestler, and W. K. Cavenee, Eds., pp. 152–155, International Agency for Research on Cancer IARC, Lyon, France, 4th edition, 2007.

D. E. Aguirre-Quezada, J. J. Martínez-Anda, E. L. Aguilar-Ayala, LG. Chávez-Macías, and JE. Olvera-Rabiela, “Tumores de vaina de nervio periférico intracraneanos e intrarraquídeos: informe de 20 casos de autopsia,” Revista de Neurología, vol. 43, no. 4, pp. 197–200, 2006.

S. Currán-Meléndez, M. Fukui, W. Bivin, and D. Oliver-Smith, “An intraventricular schwannoma with associated hydrocephalus and ventricular entrapment: a case report,” Journal of Neurological Surgery Reports, vol. 76, no. 1, pp. e32–e36, 2015.

W. Luo, X. Ren, S. Chen, H. Liu, D. Sui, and S. Lin, “Intracranial intraparenchymal and intraventricular schwannomas: report of 18 cases,” Clinical Neurology and Neurosurgery, vol. 115, no. 7, pp. 1052–1057, 2013.

H. Abdolhosseinpour, P. Vahedi, M. Saatian, A. Entezari, M. Narimani-Zamanabadi, and R. S. Tubbs, “Intraventricular schwannoma in a child. Literature review and case illustration,” Child's Nervous System, vol. 32, no. 6, pp. 1135–1140, 2016.

T. R. Hodges, I. O. Karikari, S. M. Nimjee et al., “Fourth ventricular schwannoma: identical clinicopathologic features as schwann cell-derived schwannoma with unique etiopathologic origins,” Case Reports in Medicine, vol. 2011, Article ID 165954, 4 pages, 2011.

L. P. De Vasconcellos, A. R. L. Dos Santos, J. C. E. Veiga, I. Schilemann, and C. L. P. Lancellotti, “Supratentorial intraventricular schwannoma of the choroid plexus,” Arquivos de Neuro-Psiquiatria, vol. 67, no. 4, pp. 1100–1102, 2009.

M. David, J. F. Guyot, J. Ballivet, and M. Sachs, “Schwannoid tumor of the lateral ventricle,” Neurochirurgie, vol. 11, no. 6, pp. 578–581, 1965.

N. R. Ghatak, C. W. Norwood, and C. H. Davis, “Intracerebral schwannoma,” Surgical Neurology, vol. 3, no. 1, pp. 45–47, 1975.

M. J. Van Rensburg, N. S. Proctor, J. Danziger, and M. S. Orelowitz, “Temporal lobe epilepsy due to an intracerebral Schwannoma: case report,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 38, no. 7, pp. 703–709, 1975.

J. Pimentel, L. Tavora, M. L. Cristina, and J. A. F. L. Antunes, “Intraventricular schwannoma,” Child's Nervous System, vol. 4, no. 6, pp. 373–375, 1988.

A. H. Ost and R. Meyer, “Cystic intraventricular schwannoma: a case report,” American Journal of Neuroradiology, vol. 11, no. 6, pp. 1262–1264, 1990.

G. Redekop, K. Elisevich, and J. Gilbert, “Fourth ventricular schwannoma. Case report,” Journal of Neurosurgery, vol. 73, no. 5, pp. 777–781, 1990.

H. L. Weiner, D. Zagzag, R. Babu, H. J. Weinreb, and J. Ransohoff, “Schwannoma of the fourth ventricle presenting with hemifacial spasm—a report of two cases,” Journal of Neuro-Oncology, vol. 15, no. 1, pp. 37–43, 1993.

M. D. Barbosa, O. Rebelo, P. Barbosa, J. Gonçalves, and R. Fernandes, “Cystic intraventricular schwannoma: case report and review of the literature,” Neurocirugia, vol. 12, no. 1, pp. 56–60, 2001.

M. J. Estrada, G. Sánchez-Rodríguez, R. Farías-García, and A. L. Calderón-Garcidueñas, “Schwannoma del Cuarto Ventrículo,” Revista Médica del Instituto Mexicano del Seguro Social, vol. 40, no. 5, pp. 405–408, 2002.

E. Erdogan, Ö. Öngürü, N. Bulakbasi, A. Baysefer, F. Gezen, and E. Timurkaynak, “Schwannoma of the lateral ventricle: eight-year follow-up and literature review,” Minimally Invasive Neurosurgery, vol. 46, no. 1, pp. 50–53, 2003.

G. R. Dow, A. Hussein, and I. J. Robertson, “Supratentorial intraventricular schwannoma,” British Journal of Neurosurgery, vol. 18, no. 5, pp. 561–562, 2004.

A. M. Messing-Jünger, M. J. Riemenschneider, and G. Reifenberger, “A 21-year-old female with a third ventricular tumor,” Brain Pathology, vol. 16, no. 1, pp. 87–93, 2006.

M. Lévêque, C. Gilliard, C. Godfraind, M.-M. Ruchoux, and T. Gustin, “Intraventricular schwannoma: a case report,” Neurochirurgie, vol. 53, no. 5, pp. 383–386, 2007.

W. J. Benedict Jr., H. G. Brown, G. Sivarajan, and V. C. Prabhu, “Intraventricular schwannoma in a 15-year-old adolescent: a case report,” Child's Nervous System, vol. 24, no. 4, pp. 529–532, 2008.

M. F. Oertel, K. W. Nolte, M. Blaum, J. Weis, J. M. Gilsbach, and M. C. Korinth, “Primary intraventricular schwannomas,” Clinical Neurology and Neurosurgery, vol. 111, no. 9, pp. 768–773, 2009.

S. Martin, P. Vladimír, K. Sona, K. Leoš, and S. Andrea, “Schwannoma of the third ventricle—a case report,” Asian Journal of Neurosurgery, vol. 5, no. 1, pp. 83–86, 2010.

R. Kachhara, P. Raje, and A. Pauranik, “Schwannoma originating in lateral recess of the fourth ventricle,” Asian Journal of Neurosurgery, vol. 7, no. 3, pp. 151–153, 2012.

L.-H. Chen, H.-T. Zhang, R.-X. Xu et al., “Primary fourth ventricular solitary schwannoma: case report and review of the literature,” Neurology India, vol. 61, no. 3, pp. 330–332, 2013.

R. Jaimovich, S. G. Jaimovich, N. Arakaki, and G. Sevlever, “Supratentorial intraventricular solitary schwannoma. Case report and literature review,” Child's Nervous System, vol. 29, no. 3, pp. 499–504, 2013.

F. Alberione, D. Welter, B. Peralta, J. Schulz, H. Asmus, and W. Brennan, “Intraventricular schwannoma of the choroid plexus. Case report and review of the literature,” Neurocirugia, vol. 24, no. 6, pp. 272–276, 2013.

M. Li, J. Kong, J. Sun, and X. Li, “Third ventricular schwannoma with hydrocephalus,” Journal of Clinical Neuroscience, vol. 22, no. 5, pp. 919–921, 2015.

R. Glikstein, A. Biswas, G. Mohr, and S. Albrecht, “Supratentorial paraventricular schwannoma,” The Neuroradiology Journal, vol. 28, no. 1, pp. 46–50, 2015.

L. Marchand, P. Koechlin, and Y. Racine, “Malignant neurinoma of the fourth ventricle with intrabulbar propagation in a schizophrenic; death during electroshock,” Annales Médico-Psychologiques, vol. 115, no. 1, pp. 108–113, 1957.

J.-M. Jung, H.-Y. Shin, J. G. Chi, I. S. Park, E. S. Kim, and J. W. Han, “Malignant intraventricular schwannoma. Case report,” Journal of Neurosurgery, vol. 82, no. 1, pp. 121–124, 1995.

Y. Takahashi, Y. Sugita, T. Abe, T. Yuge, T. Tokutomi, and M. Shigemori, “Intraventricular malignant triton tumour,” Acta Neurochirurgica, vol. 142, no. 4, pp. 473–477, 2000.

M. Benedikt, “Ueber die Innervation des Plexus chorioideus inferior,” Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin, vol. 59, no. 3-4, pp. 395–400, 1874.

P. Stöhr, “Ueber die Innervation des Plexus Choroideus des Menschen,” Zeitschrift für die Gesamte Anatomie, vol. 63, pp. 562–607, 1922.

F. Doetsch, I. Caillé, D. A. Lim, J. M. García-Verdugo, and A. Álvarez-Buylla, “Subventricular zone astrocytes are neural stem cells in the adult mammalian brain,” Cell, vol. 97, no. 6, pp. 703–716, 1999.